Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$241.42 - $282.29 $21,969 - $25,688
-91 Reduced 6.18%
1,382 $366,000
Q3 2022

Nov 15, 2022

SELL
$247.06 - $1507.4 $68,929 - $420,564
-279 Reduced 15.92%
1,473 $380,000
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $60,700 - $76,712
256 Added 17.11%
1,752 $444,000
Q1 2022

May 09, 2022

BUY
$257.27 - $315.76 $153,847 - $188,824
598 Added 66.59%
1,496 $439,000
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $33,589 - $37,836
-115 Reduced 11.35%
898 $295,000
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $1,633 - $1,994
6 Added 0.6%
1,013 $308,000
Q1 2021

May 13, 2021

BUY
$212.38 - $245.9 $213,866 - $247,621
1,007 New
1,007 $227,000
Q3 2019

Nov 12, 2019

SELL
$135.4 - $146.47 $2.4 Million - $2.59 Million
-17,690 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$124.88 - $143.73 $81,047 - $93,280
-649 Reduced 3.54%
17,690 $2.53 Million
Q1 2019

May 13, 2019

SELL
$97.62 - $132.29 $751,088 - $1.02 Million
-7,694 Reduced 29.55%
18,339 $2.42 Million
Q4 2018

Feb 12, 2019

SELL
$94.85 - $109.54 $115,527 - $133,419
-1,218 Reduced 4.47%
26,033 $2.69 Million
Q3 2018

Nov 13, 2018

SELL
$98.13 - $108.9 $45,728 - $50,747
-466 Reduced 1.68%
27,251 $2.96 Million
Q2 2018

Aug 13, 2018

SELL
$96.1 - $103.24 $33,250 - $35,721
-346 Reduced 1.23%
27,717 $2.74 Million
Q1 2018

May 08, 2018

SELL
$92.16 - $103.8 $62,115 - $69,961
-674 Reduced 2.35%
28,063 $2.75 Million
Q4 2017

Feb 13, 2018

BUY
$85.26 - $94.62 $309,579 - $343,565
3,631 Added 14.46%
28,737 $2.67 Million
Q3 2017

Nov 13, 2017

SELL
$79.29 - $88.45 $55,265 - $61,649
-697 Reduced 2.7%
25,106 $2.14 Million
Q3 2017

Nov 09, 2017

BUY
$79.29 - $88.45 $2.05 Million - $2.28 Million
25,803
25,803 $2.17 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Burney CO Portfolio

Follow Burney CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.